ICCM
IceCure Medical·NASDAQ
--
--(--)
--
--(--)
5.76 / 10
Netural
Fund flow metrics score 7.51/10, revealing robust fund flow characteristics. Beneficial no significant trends trends are challenged by problematic overall, block, Small, Medium, Large, and Extra-large signals, indicating positive capital movement. The analyst community expresses overwhelmingly bullish analyst consensus with strong conviction. Ratings composition: Strong Buy(100.0%) representing 1 analyst views, supported by 4.02 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-10-07
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate50.0%
What is the analyst consensus for ICCM?
- ICCM holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.76/10 (Netural).
